I actually think mRNA technology has great potential - especially in cancer and rare diseases. Even early ideas from Moderna around mRNA and stem cell rejuvenation were interesting.However, using it as a vaccine platform is fundamentally different from using it as a cancer drug. The safety tolerance for something given to a large population should be extremely high - closer to aviation than oncology.These were rushed to market, and agencies like FDA and NIH projected a level of certainty about s